Opportunity ID: 318262

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-313
Funding Opportunity Title: Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 – Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.859 — Biomedical Research and Research Training
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 10, 2019
Last Updated Date: Jul 10, 2019
Original Closing Date for Applications: Jan 27, 2022
Current Closing Date for Applications: Jan 27, 2022
Archive Date: Mar 04, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details.

Additional Information

Agency Name: National Institutes of Health
Description: The National Institute of General Medical Sciences (NIGMS) invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at Universities that award doctoral degrees in the health-related sciences or independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by NIH or other federal agencies within Institutional Development Award (IDeA)-eligible states. The objectives of the COBRE initiative are to strengthen an institution’s biomedical research infrastructure through the establishment of a thematic multi-disciplinary center and to enhance the ability of investigators to compete independently for NIH individual research grants or other external peer-reviewed support. COBRE awards are supported through the IDeA Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-313.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 318262 Full Announcement-PAR-19-313 -> PAR-19-313-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00252832 Dec 28, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00258980 Dec 28, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269904 Oct 29, 2021 Jan 27, 2022 View

Package 1

Mandatory forms

318262 RR_SF424_2_0-2.0.pdf

318262 PHS398_CoverPageSupplement_4_0-4.0.pdf

318262 RR_OtherProjectInfo_1_4-1.4.pdf

318262 PerformanceSite_2_0-2.0.pdf

318262 RR_KeyPersonExpanded_2_0-2.0.pdf

318262 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

318262 PHS_Additional_IndirectCosts-1.0.pdf

318262 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

318262 RR_SF424_2_0-2.0.pdf

318262 PHS398_CoverPageSupplement_5_0-5.0.pdf

318262 RR_OtherProjectInfo_1_4-1.4.pdf

318262 PerformanceSite_2_0-2.0.pdf

318262 RR_KeyPersonExpanded_2_0-2.0.pdf

318262 PHS398_ResearchPlan_4_0-4.0.pdf

318262 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

318262 PHS_Additional_IndirectCosts-1.0.pdf

318262 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

318262 RR_SF424_5_0-5.0.pdf

318262 PHS398_CoverPageSupplement_5_0-5.0.pdf

318262 RR_OtherProjectInfo_1_4-1.4.pdf

318262 PerformanceSite_4_0-4.0.pdf

318262 RR_KeyPersonExpanded_4_0-4.0.pdf

318262 PHS398_ResearchPlan_4_0-4.0.pdf

318262 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

318262 PHS_Additional_IndirectCosts_2_0-2.0.pdf

318262 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T20:51:28-05:00

Share This Post, Choose Your Platform!

About the Author: